Anthem Biosciences IPO Peer Comparison: EPS, ROCE, ROE, P/E, P/Bv, Debt/Equity & RoNW

Anthem Biosciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Anthem Biosciences IPO: Comprehensive Peer Comparison with CRDMO Companies
This peer comparison evaluates Anthem Biosciences IPO against key competitors like Syngene International Limited, Sai Life Sciences Limited, Cohance Lifesciences Limited (Formerly Suven Pharmace uticals) and Divi’s Laboratories Limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these CRDMO Company. This comparison highlights the strengths and positioning of Anthem Biosciences in the competitive landscape of the CRDMO Industry.

Anthem Biosciences Limited IPO Peer Comparison
Company Name	EPS	ROCE	ROE	P/E (x)	P/Bv	Debt/Equity	RoNW (%)
Anthem Biosciences Limited	₹ 8.04	27.64 %	20.82 %	70.94	13.23	0.05	20.82 %
Syngene International Limited	₹ 12.3	13.5 %	10.5 %	54.1	5.42	0.12	10.5 %
Sai Life Sciences Limited	₹ 8.32	13.9 %	10.9 %	94.5	7.54	0.13	10.9 %
Cohance Lifesciences Limited (Formerly Suven Pharmaceuticals)	₹ 10.5	16.8 %	14.1 %	144	14.9	0.16	14.1 %
Divis Laboratories Limited	₹ 82.5	20.4 %	15.4 %	83.3	12.2	0.00	15.4 %